National AIDS Control Programme urged to move beyond medicine-centric approach The government programmes for children suffering from HIV/AIDS should move from medicine-centric approach to include nutrition and preventive care, the National Commission for Protection of Child Rights (NCPCR) has recommended. In its recently released report ‘Rights and entitlements of children affected and infected by HIV/AIDS 2010-11’, the organisation also advocated provisions for issuing BPL cards to children who have lost their...

-The Indian Express Gay rights activists today submitted in Supreme Court that criminalising homosexual acts is against constitutional values and that the law should not interfere when consenting adults are involved. Naz Foundation, an NGO working for the welfare and rehabilitation of HIV infected people, contended that homosexuals face social ostracism with gay sex being declared as an offence. Appearing before a bench of justices G S Singhvi and S J Mukhopadhaya, the...

-PTI India has an estimated 25 lakh gay population and about 7 per cent of them are HIV-infected, the government today told the Supreme Court. “The population of MSM (men who have sex with men) is estimated to be 25 lakh in India,” the government said in its affidavit filed in the court, citing figures of the National Aids Control programme. The affidavit, filed by the health ministry, said it is planning to...

India's use of the compulsory licensing provision under its patents law for the first time to make the patented cancer drug Nexavar available at affordable prices is an essential, although belated step to curb the mounting cost of drugs. The grant of the licence by the Controller-General of Patents, Designs and Trade Marks to Natco Pharma for manufacture of the drug Sorafenib Tosylate (Nexavar) to treat liver and kidney cancer is...

-Reuters India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say.  On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug...